课题基金 / 基金详情

COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)

COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)
COVID-19 疫苗诱发的炎症性心脏病患病率登记和队列研究 (COVID-VIHPR)
批准号：
452771
负责人：
Liu Peter P
金额：
$59.07万
依托单位：
Ottawa Heart Institute Research Corporation (Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-09-01 至 2025-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452771&lang=en
关键词：
Biomarkers Cardiac Imaging Covid-19 Follow Up Innate Immunity Myocarditis Pericarditis Vaccines

项目摘要

项目成果

Liu Peter P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As COVID-19 vaccination efforts have accelerated in Canada, reports of vaccine-induced complications, including inflammation of the heart have emerged. We have collated the worldwide experience, and together with colleagues and experts convened by Canada'
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The COVID-R3ICSAB Study: COVID-19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations
COVID-19 Variant Supplement - Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
Developing Novel Therapeutic Targets for Heart Failure
海外基金